There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Microbot Medical (MBOT) and Navidea (NAVB) with bullish sentiments.
Microbot Medical (MBOT)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Microbot Medical today and set a price target of $10.00. The company’s shares closed last Monday at $4.63.
According to TipRanks.com, Selvaraju is currently ranked with no stars on a 0-5 star ranking scale, with an average return of -12.9% and a 30.3% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Taro Pharmaceutical Industries, Turning Point Therapeutics, and Biospecifics Technologies.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Microbot Medical with a $10.00 average price target.
See today’s analyst top recommended stocks >>
Navidea (NAVB)
H.C. Wainwright analyst Vernon Bernardino initiated coverage with a Buy rating on Navidea today and set a price target of $3.00. The company’s shares closed last Monday at $0.68.
According to TipRanks.com, Bernardino has currently no stars on a ranking scale of 0-5 stars, with an average return of -8.9% and a 28.4% success rate. Bernardino covers the Healthcare sector, focusing on stocks such as Innovus Pharmaceuticals, Jaguar Animal Health, and Seelos Therapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Navidea with a $2.50 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
